Betadine 1%100 ml

Betadine 1% is a broad-spectrum topical antiseptic with the following evidence-based uses:

• Established/labeled use: Pre-operative and pre-injection skin preparation to reduce the risk of infection at the puncture or incision site.
• Established/labeled use: First-aid antisepsis of minor cuts, scrapes, and superficial wounds to help prevent bacterial contamination.
• Established/labeled use (specific formulations only): Short-term antisepsis of the mouth and throat when supplied as a 1% gargle/mouthwash preparation.
• Adjunct/guideline-supported use: Adjunctive antiseptic cleansing of infected superficial wounds, minor burns, and pyodermas alongside standard wound care.
• Use requiring a specific labeled product: Vaginal antisepsis, only with a formulation specifically labeled and marketed for vaginal use, and generally under medical advice.

Betadine 1% is not a systemic antibiotic; it does not treat systemic or deep-tissue infections and is not a substitute for prescribed systemic antimicrobial therapy when that is indicated.

Povidone Iodine is available in several topical dosage forms, each containing povidone-iodine (an iodophor complex of iodine with the polymer povidone) as the active antimicrobial ingredient. Common strengths marketed include:

• Solution: 5% or 10% w/v povidone-iodine
• Ointment/Cream: 5% w/w povidone-iodine
• Gargle/Mouthwash: 1% w/v povidone-iodine
• Surgical scrub: 7.5% w/v povidone-iodine with a mild surfactant base
• Vaginal gel: 10% w/w povidone-iodine
• Topical powder/spray: 2.5%–5% povidone-iodine

Exact excipients vary by manufacturer and formulation; always check the label of the specific brand dispensed.

Betadine 1% is a broad-spectrum topical antiseptic belonging to the iodophor class. It is a stable chemical complex of elemental iodine with the water-soluble polymer povidone, which acts as a carrier and slowly releases free iodine at the site of application.

Because the iodine is bound to povidone, Betadine 1% is less irritating and less likely to stain or sting than free aqueous or tincture iodine preparations, while retaining potent antimicrobial activity. It is widely used in hospital and household settings for skin antisepsis, wound care, and pre-procedural skin preparation.

Topical Antiseptic and Disinfectant (Iodophor)

Povidone Iodine exerts antimicrobial activity through the sustained release of free iodine from the povidone-iodine complex on contact with skin, mucous membranes, or wound exudate.

Free iodine rapidly penetrates the cell walls of microorganisms and oxidizes and iodinates key cellular components, including proteins, nucleotides, and fatty acids, leading to disruption of protein synthesis and cell membrane structure and ultimately cell death.

This mechanism gives Povidone Iodine a broad spectrum of activity against gram-positive and gram-negative bacteria (including some resistant strains), fungi, viruses, protozoa, and bacterial spores, with a low potential for microorganisms to develop resistance.

Betadine 1% is for external topical use (or oral/mucosal use only for products specifically labeled as a gargle, mouthwash, or vaginal preparation). General administration points:

• Clean and, where possible, dry the area before application.
• Apply undiluted unless the product label specifically directs dilution (e.g., some gargle preparations).
• Allow the solution to dry on the skin for its full antiseptic effect before covering or beginning a procedure.
• Avoid contact with the eyes; if accidental eye contact occurs, rinse thoroughly with water.
• Do not apply over large areas of denuded or broken skin, or use on serious burns, without a doctor's advice.
• Wash hands after application unless the hands are the treated area.

Well-documented clinically significant interactions with Betadine 1% are limited, since systemic absorption is normally minimal with correct topical use. Notable interactions include:

• Lithium: Concurrent regular/prolonged use of Betadine 1% with lithium therapy should be avoided, as both can affect thyroid function; combined exposure may increase the risk of hypothyroidism.
• Other topical antiseptics (e.g., hydrogen peroxide, chlorhexidine, mercury-containing antiseptics, silver-containing products): Do not mix or apply sequentially without rinsing, as these can chemically inactivate each other or, in the case of mercury compounds, form irritant/corrosive complexes.
• Thyroid function tests / radioactive iodine uptake studies: Betadine 1% can be absorbed systemically and interfere with thyroid function tests and radioiodine uptake studies; inform the laboratory/physician of recent use.
• Enzymatic wound débriding agents: Betadine 1% may inactivate certain enzymatic debriding agents when used on the same wound.

Betadine 1% is generally well tolerated when used as directed. Reported side effects include:

• Common: Local skin irritation, transient staining of skin/clothing, mild stinging or burning sensation at the application site.
• Less common: Allergic contact dermatitis (redness, itching, rash, swelling).
• Rare but serious: Severe hypersensitivity reactions (including anaphylaxis); with extensive/prolonged use over large denuded skin areas or serious burns — systemic iodine absorption leading to metabolic acidosis, hypernatremia, renal impairment, or altered thyroid function.

Discontinue Betadine 1% and seek medical advice if a rash, marked redness, swelling, or signs of an allergic reaction develop.

Pregnancy: Occasional, limited topical use of Betadine 1% on small areas of intact skin is generally considered low risk because systemic absorption is minimal. However, regular, prolonged, or extensive use (e.g., as a routine vaginal douche, regular gargle, or over large wound/burn areas) should be avoided during pregnancy, as absorbed iodine can cross the placenta and theoretically affect fetal thyroid function. Betadine 1% should be used in pregnancy only if clearly needed and the potential benefit justifies the potential risk; consult a physician before regular or extensive use.

Breastfeeding: Iodine absorbed from Betadine 1% can be excreted in breast milk and may affect the infant's thyroid function with regular or extensive maternal use, particularly if applied near the breast/nipple area. Limit use to small areas, avoid application to the nipple/areola before breastfeeding, and consult a physician for regular or extensive use during lactation.

Betadine 1% is for external/topical use, or mucosal use only for products specifically labeled for that purpose (e.g., gargle, vaginal gel); do not swallow or inject.

• Avoid contact with the eyes; if contact occurs, rinse thoroughly with water.
• Discontinue use and consult a physician if irritation, redness, or an allergic reaction develops, or if the condition being treated does not improve or worsens after a few days.
• Avoid extensive, prolonged, or repeated application over large areas of broken skin, deep or puncture wounds, or serious burns, because systemic iodine absorption may occur, which is of particular concern in patients with thyroid disorders, renal impairment, pregnant women, neonates, and infants.
• Use with caution and only under medical advice in patients with a history of thyroid disease (e.g., goiter, Hashimoto's thyroiditis, hyperthyroidism), as regular use can affect thyroid hormone levels.
• Neonates and young infants have a higher risk of systemic iodine absorption and thyroid suppression; use only under medical supervision, with the smallest effective area and duration.
• Not for use in body cavities (other than as specifically labeled, e.g., gargle) or in individuals with known iodine sensitivity.
• If swallowed accidentally, seek immediate medical attention (see Overdose Effects).

Overdose or excessive systemic absorption of Betadine 1% can occur from accidental ingestion, or from extensive/prolonged application to large wound or burn surfaces. Features may include: nausea, vomiting, abdominal pain, diarrhea, mucosal irritation/burns of the mouth and throat, metallic taste, electrolyte disturbances (e.g., hypernatremia), metabolic acidosis, acute kidney injury, cardiovascular collapse, and thyroid dysfunction.

If accidental ingestion or signs of systemic toxicity occur, seek immediate medical attention or contact a poison control center/emergency services right away. Do not attempt specific home treatment; management should be supportive care under medical supervision.

Store at room temperature (below 30°C), away from light and moisture, and keep the container tightly closed. Keep out of reach of children.

Neonates and infants: Use Betadine 1% with caution in neonates, particularly premature infants, due to a higher risk of systemic iodine absorption and transient hypothyroidism; limit to the smallest area and shortest duration necessary, and use only under medical supervision.

Elderly: No specific dose adjustment is generally required for topical use; use with the same precautions regarding skin integrity and thyroid disease as in other adults.

Renal impairment: Use with caution and avoid extensive or prolonged application, as reduced renal clearance of absorbed iodine may increase the risk of systemic iodine accumulation.

Hepatic impairment: No specific data suggest a need for dose adjustment with normal topical use; general precautions regarding extensive use still apply.

Thyroid disease: Use only under medical advice; see Precautions and Warnings.

Duration of use of Betadine 1% depends on the formulation and indication: general skin antisepsis and minor wound care should generally not exceed 7 days of continuous use without medical advice; gargle/mouthwash use should generally not exceed 14 days. Pre-operative or pre-injection skin preparation is a single, brief application per procedure. If the condition being treated persists, worsens, or does not improve within a few days, stop use and consult a physician.

Iodophors; Topical Antiseptics and Disinfectants

Povidone Iodine works by slowly releasing free iodine from its complex with povidone upon contact with skin, mucosa, or wound fluid. Free iodine oxidizes and iodinates microbial proteins, enzymes, and nucleic acids, disrupting essential cellular processes and the microbial cell membrane, which results in rapid, broad-spectrum microbicidal activity against bacteria, fungi, viruses, and protozoa.

Topical use of Betadine 1% in older children and adolescents follows the same general precautions as in adults, applied to the smallest necessary area for the shortest effective duration.

In neonates and infants, particularly premature or low-birth-weight infants, safety and efficacy of repeated or extensive use have not been well established; there is an increased risk of systemic iodine absorption and transient hypothyroidism with regular or extensive application. Use in this age group only under direct medical supervision, limiting the area and frequency of application, and monitor thyroid function if repeated use is medically necessary. Povidone-iodine dusting powder and similar concentrated formulations are generally not recommended for children under 2 years of age.